Gallium 68 (68Ga)–labeled fibroblast activation protein (FAP) inhibitor (FAPI) PET is based
on the molecular targeting of the FAP, which is known to be highly expressed in the major …

In recent years, quinoline-based fibroblast activation protein (FAP) inhibitors (FAPI) have
shown promising results in the diagnosis of cancer and several other diseases, making them …

Fibroblast activation protein (FAP), a type II transmembrane serine protease, is highly
expressed in more than 90% of epithelial tumors and is closely associated with various …

Fibroblast activation protein (FAP) is a type II membrane-bound glycoprotein which is
overexpressed in cancer-associated fibroblasts and activated fibroblasts at wound …

Purpose The study aimed to provide a comprehensive bibliometric overview of the current
scientific publications on fibroblast activation protein inhibitor (FAPI) positron emission …

Purpose Several studies have demonstrated that 68Ga-FAPI PET/CT shows high
intratumoral tracer uptake and low normal tissue uptake, allowing for excellent visualization …

Purpose This study was designed to compare the performance of 68Ga-FAPI-04 and 18F-
FDG PET/CT for initial staging and recurrence detection of head and neck squamous cell …

FAPI-based radiopharmaceuticals are a novel class of tracers, mainly used for PET imaging,
which have demonstrated several advantages over [18F] FDG, especially in the case of low …

Simple Summary Fibroblast activation protein is a newly discovered biomarker in various
tumor types. Using inhibitors ligated with radiopharmaceuticals, nuclear medicine …

Several studies have examined the use of positron emission tomography (PET) using [68Ga]
Ga-radiolabeled fibroblast-activation protein inhibitors (FAPi) across multiple subtypes of …